Trade SRZN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Surrozen, Inc. (SRZN) is trading at US$16.55, down 2.30% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$281.97M. Over the past 52 weeks, SRZN has traded between US$11.39 and US$35.00. On Syfe you can trade SRZN with $0 commission and add it to your watchlist.
| Previous close | US$16.94 |
|---|---|
| Market cap | US$281.97M |
| 52-week range | US$11.39 – US$35.00 |
| Volume | 190.17K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Surrozen, Inc.
Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.
Year: 2021
William Blair Initiates Surrozen at Outperform
Aug 20, 10:54 AM · MT Newswires
TD Cowen Initiates Surrozen at Buy
Apr 21, 11:26 AM · MT Newswires
Surrozen, Inc. (SRZN) stock is trading at US$16.55, -2.30% from the previous close of US$16.94.
The market cap for Surrozen, Inc. (SRZN) stock is approximately US$281.97M.
The 52-week high for Surrozen, Inc. (SRZN) stock is US$35.00.
The 52-week low for Surrozen, Inc. (SRZN) stock is US$11.39.
Surrozen, Inc. (SRZN) does not currently pay a dividend.
Stay on top of SRZN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
